Company: NCEL
Filing Date: 2025-02-05
Form Type: F-3
Source: 0001213900-25-010223
Chunk: 59

Company: NewcelX Ltd.
Filing Date: 2025-02-05
Form: F-3
Chunk 59
---
 financial condition, results of operations, and cash flows could be adversely affected over time.

Kadimastem may fail to realize some or all of the anticipated benefits of the proposed Merger, which may adversely affect the value of each Kadimastem ordinary share.

The success of the Merger will depend, in part, on Kadimastem’s ability to realize the anticipated benefits from combining Kadimastem and NLS. However, to realize these anticipated benefits, the businesses of Kadimastem and NLS must be successfully combined and the two companies’ respective operations, technologies and personnel must be integrated following the closing of the merger. If Kadimastem is not able to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits and cost savings of the Merger may not be realized fully or at all or may take longer to realize than expected and the value of Kadimastem’s ordinary shares may be adversely affected. In addition, the overall integration of the businesses is a complex, time-consuming and expensive process that, without proper planning and effective and timely implementation, could significantly disrupt Kadimastem’s operations following closing.

<div align='center'>40</div>

Specifically, risks in integrating NLS into Kadimastem’s operations to realize the anticipated benefits of the Merger include, among other things, the failure to:

| ● | effectively coordinate                                                           
 efforts to communicate Kadimastem’s capabilities and products following closing; |

| ● | compete effectively for                                                            
 additional opportunities expected to be available to Kadimastem following closing; |

| ● | integrate and harmonize                                                       
 financial reporting and information technology systems of Kadimastem and NLS; |

| ● | retain Kadimastem’s                                                                                
 relationships with its customers and successfully integrate NLS into these existing relationships; |

| ● | integrate the NLS and Kadimastem 
 senior management teams;         |

| ● | retain and integrate key      
 NLS and Kadimastem employees; |

| ● | successfully address Kadimastem’s 
 existing liabilities;             |

| ● | coordinate operations across         
 time zones, continents and cultures; |

| ● | manage the diversion of                                             
 management’s attention from business matters to integration issues; |

| ● | retain customers; and |

| ● | combine                                                                                                                    
 Kadimastem’s business and management culture with the business and management culture of NLS. For more information, please 
 see “Risks Related to the Merger